William J Gradishar, Meena S Moran, Jame Abraham, Vandana Abramson, Rebecca Aft, Doreen Agnese, Kimberly H Allison, Bethany Anderson, Janet Bailey, Harold J Burstein, Nan Chen, Helen Chew, Chau Dang, Anthony D Elias, Sharon H Giordano, Matthew P Goetz, Rachel C Jankowitz, Sara H Javid, Jairam Krishnamurthy, A Marilyn Leitch, Janice Lyons, Susie McCloskey, Melissa McShane, Joanne Mortimer, Sameer A Patel, Laura H Rosenberger, Hope S Rugo, Cesar Santa-Maria, Bryan P Schneider, Mary Lou Smith, Hatem Soliman, Erica M Stringer-Reasor, Melinda L Telli, Mei Wei, Kari B Wisinski, Kay T Yeung, Jessica S Young, Ryan Schonfeld, Rashmi Kumar
{"title":"Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.","authors":"William J Gradishar, Meena S Moran, Jame Abraham, Vandana Abramson, Rebecca Aft, Doreen Agnese, Kimberly H Allison, Bethany Anderson, Janet Bailey, Harold J Burstein, Nan Chen, Helen Chew, Chau Dang, Anthony D Elias, Sharon H Giordano, Matthew P Goetz, Rachel C Jankowitz, Sara H Javid, Jairam Krishnamurthy, A Marilyn Leitch, Janice Lyons, Susie McCloskey, Melissa McShane, Joanne Mortimer, Sameer A Patel, Laura H Rosenberger, Hope S Rugo, Cesar Santa-Maria, Bryan P Schneider, Mary Lou Smith, Hatem Soliman, Erica M Stringer-Reasor, Melinda L Telli, Mei Wei, Kari B Wisinski, Kay T Yeung, Jessica S Young, Ryan Schonfeld, Rashmi Kumar","doi":"10.6004/jnccn.2024.0035","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer is treated with a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget's disease, Phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of systemic therapy (preoperative and adjuvant) options for nonmetastatic breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.</p>","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":null,"pages":null},"PeriodicalIF":14.8000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Comprehensive Cancer Network","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6004/jnccn.2024.0035","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Breast cancer is treated with a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget's disease, Phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of systemic therapy (preoperative and adjuvant) options for nonmetastatic breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.
期刊介绍:
JNCCN—Journal of the National Comprehensive Cancer Network is a peer-reviewed medical journal read by over 25,000 oncologists and cancer care professionals nationwide. This indexed publication delivers the latest insights into best clinical practices, oncology health services research, and translational medicine. Notably, JNCCN provides updates on the NCCN Clinical Practice Guidelines in Oncology® (NCCN Guidelines®), review articles elaborating on guideline recommendations, health services research, and case reports that spotlight molecular insights in patient care.
Guided by its vision, JNCCN seeks to advance the mission of NCCN by serving as the primary resource for information on NCCN Guidelines®, innovation in translational medicine, and scientific studies related to oncology health services research. This encompasses quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship.
JNCCN boasts indexing by prominent databases such as MEDLINE/PubMed, Chemical Abstracts, Embase, EmCare, and Scopus, reinforcing its standing as a reputable source for comprehensive information in the field of oncology.